These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31325705)

  • 41. Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system.
    Zhang S; Lu C; Zhang X; Li J; Jiang H
    Drug Deliv; 2016 Jun; 23(5):1838-45. PubMed ID: 26879035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy.
    Zhang C; Zhao Y; Zhang E; Jiang M; Zhi D; Chen H; Cui S; Zhen Y; Cui J; Zhang S
    Drug Deliv; 2020 Dec; 27(1):1397-1411. PubMed ID: 33096948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design.
    Kaur P; Garg T; Rath G; Murthy RS; Goyal AK
    Drug Deliv; 2016 Jul; 23(6):1912-25. PubMed ID: 25544602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcription activator, hyaluronic acid and tocopheryl succinate multi-functionalized novel lipid carriers encapsulating etoposide for lymphoma therapy.
    Wang H; Sun G; Zhang Z; Ou Y
    Biomed Pharmacother; 2017 Jul; 91():241-250. PubMed ID: 28460227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Co-delivery of paclitaxel and cetuximab by nanodiamond enhances mitotic catastrophe and tumor inhibition.
    Lin YW; Raj EN; Liao WS; Lin J; Liu KK; Chen TH; Cheng HC; Wang CC; Li LY; Chen C; Chao JI
    Sci Rep; 2017 Aug; 7(1):9814. PubMed ID: 28852020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: Systematic development, characterization and pharmacokinetic evaluation.
    Poonia N; Kaur Narang J; Lather V; Beg S; Sharma T; Singh B; Pandita D
    Colloids Surf B Biointerfaces; 2019 Sep; 181():756-766. PubMed ID: 31234063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy.
    Chen Z; Lai X; Song S; Zhu X; Zhu J
    Drug Deliv; 2016 May; 23(4):1369-73. PubMed ID: 26017099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surface-engineered nanostructured lipid carrier systems for synergistic combination oncotherapy of non-small cell lung cancer.
    Rawal S; Bora V; Patel B; Patel M
    Drug Deliv Transl Res; 2021 Oct; 11(5):2030-2051. PubMed ID: 33215254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against
    Tian B; Yan Q; Wang J; Ding C; Sai S
    Int J Nanomedicine; 2017; 12():7131-7141. PubMed ID: 29026306
    [No Abstract]   [Full Text] [Related]  

  • 50. Matrix metalloproteinase 2/9-triggered-release micelles for inhaled drug delivery to treat lung cancer: preparation and in vitro/in vivo studies.
    Wang X; Chen Q; Zhang X; Ren X; Zhang X; Meng L; Liang H; Sha X; Fang X
    Int J Nanomedicine; 2018; 13():4641-4659. PubMed ID: 30147314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Construction and in vitro and in vivo evaluation of folic acid-modified nanostructured lipid carriers loaded with paclitaxel and chlorin e6.
    Zhang Q; Zhao J; Hu H; Yan Y; Hu X; Zhou K; Xiao S; Zhang Y; Feng N
    Int J Pharm; 2019 Oct; 569():118595. PubMed ID: 31394189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation.
    Yue Y; Zhao D; Yin Q
    Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer.
    Yuan ZQ; Li JZ; Liu Y; Chen WL; Yang SD; Zhang CG; Zhu WJ; Zhou XF; Liu C; Zhang XN
    Int J Pharm; 2015 Aug; 492(1-2):141-51. PubMed ID: 26188316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles.
    Wang J
    Drug Des Devel Ther; 2020; 14():823-832. PubMed ID: 32161442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M; Teng L; Wang Y; Zhang J; Sun X
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fabrication and in vivo evaluation of ligand appended paclitaxel and artemether loaded lipid nanoparticulate systems for the treatment of NSCLC: A nanoparticle assisted combination oncotherapy.
    Khatri H; Chokshi N; Rawal S; Patel BM; Badanthadka M; Patel MM
    Int J Pharm; 2020 Jun; 583():119386. PubMed ID: 32376440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment.
    Yuan X; Ji W; Chen S; Bao Y; Tan S; Lu S; Wu K; Chu Q
    Int J Nanomedicine; 2016; 11():2119-31. PubMed ID: 27307727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.
    Yang XY; Li YX; Li M; Zhang L; Feng LX; Zhang N
    Cancer Lett; 2013 Jul; 334(2):338-45. PubMed ID: 22776563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate.
    Abdelbary G; Haider M
    Pharm Dev Technol; 2013; 18(5):1159-68. PubMed ID: 21958084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.